Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $20,814 - $24,390
824 Added 10.07%
9,009 $252,000
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $211,909 - $243,340
8,185 New
8,185 $227,000
Q1 2023

May 17, 2023

SELL
$39.39 - $51.28 $571,667 - $744,226
-14,513 Reduced 71.36%
5,825 $237,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $205,952 - $268,848
-4,933 Reduced 19.52%
20,338 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $22,536 - $27,511
515 Added 2.08%
25,271 $1.11 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $10,190 - $12,082
219 Added 0.89%
24,756 $1.3 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $555,313 - $688,103
-12,138 Reduced 33.1%
24,537 $1.27 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $37,518 - $55,615
908 Added 2.54%
36,675 $2.17 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $3,375 - $4,336
86 Added 0.24%
35,767 $1.56 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $384,272 - $435,316
10,701 Added 42.84%
35,681 $1.4 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $161,656 - $182,315
4,827 Added 23.95%
24,980 $905,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $474,002 - $602,734
14,162 Added 236.39%
20,153 $742,000
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $2,861 - $3,470
83 Added 1.4%
5,991 $264,000
Q2 2018

Aug 01, 2018

BUY
$32.98 - $35.16 $30,143 - $32,136
914 Added 18.3%
5,908 $214,000
Q1 2018

May 10, 2018

SELL
$31.91 - $37.02 $12,795 - $14,845
-401 Reduced 7.43%
4,994 $177,000
Q4 2017

Feb 22, 2018

BUY
$33.26 - $35.29 $179,437 - $190,389
5,395
5,395 $197,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wagner Wealth Management, LLC Portfolio

Follow Wagner Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wagner Wealth Management, LLC with notifications on news.